JBC Biosymposia, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C600253200 on October 31, 2006

J. Biol. Chem., Vol. 281, Issue 50, 38122-38126, December 15, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/50/38122    most recent
C600253200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedekind, J. E.
Right arrow Articles by Smith, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedekind, J. E.
Right arrow Articles by Smith, H. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nanostructures of APOBEC3G Support a Hierarchical Assembly Model of High Molecular Mass Ribonucleoprotein Particles from Dimeric Subunits*Formula

Joseph E. Wedekind{ddagger}1, Richard Gillilan§, Alena Janda{ddagger}2, Jolanta Krucinska{ddagger}2, Jason D. Salter{ddagger}, Ryan P. Bennett{ddagger}3, Jay Raina, and Harold C. Smith{ddagger}4

From the {ddagger}Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, the §Macromolecular Structure Facility at the Cornell High-Energy Synchrotron Source (MacCHESS), Cornell University, Ithaca, New York 14853, and Immunodiagnostics Inc., Woburn, Massachusetts 01801

Human APOBEC3G (hA3G) is a cytidine deaminase that restricts human immunodeficiency virus (HIV)-1 infection in a vif (the virion infectivity factor from HIV)-dependent manner. hA3G from HIV-permissive activated CD4+ T-cells exists as an inactive, high molecular mass (HMM) complex that can be transformed in vitro into an active, low molecular mass (LMM) variant comparable with that of HIV-non-permissive CD4+ T-cells. Here we present low resolution structures of hA3G in HMM and LMM forms determined by small angle x-ray scattering and advanced shape reconstruction methods. The results show that LMM particles have an extended shape, dissimilar to known cytidine deaminases, featuring novel tail-to-tail dimerization. Shape analysis of LMM and HMM structures revealed how symmetric association of dimers could lead to minimal HMM variants. These observations imply that the disruption of cellular HMM particles may require regulation of protein-RNA, as well as protein-protein interactions, which has implications for therapeutic development.


Received for publication, September 19, 2006 , and in revised form, October 23, 2006.

* This work was supported by Grant AI058789 from NIAID/National Institutes of Health. CHESS was supported by National Science Foundation Grant DMR 0225180, and the MacCHESS facility was supported by National Institutes of Health Grant RR-01646. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Methods, Refs. 1–6, Figs. S1–S4, and Table S1.

2 These authors contributed equally to this work.

3 Supported by National Institutes of Health Grant T32 AI49815.

1 To whom correspondence may be addressed: Dept. of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave., Box 712, Rochester, NY 14642. Tel.: 585-273-4516; Fax: 585-271-2683; E-mail: joseph_wedekind{at}urmc.rochester.edu. 4 To whom correspondence may be addressed: Dept. of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave., Box 712, Rochester, NY 14642. Tel.: 585-275-4267; Fax: 585-271-2683; E-mail: harold.smith{at}rochester.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
D. H. Nguyen and J. Hu
Reverse Transcriptase- and RNA Packaging Signal-Dependent Incorporation of APOBEC3G into Hepatitis B Virus Nucleocapsids
J. Virol., July 15, 2008; 82(14): 6852 - 6861.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chelico, E. J. Sacho, D. A. Erie, and M. F. Goodman
A Model for Oligomeric Regulation of APOBEC3G Cytosine Deaminase-dependent Restriction of HIV
J. Biol. Chem., May 16, 2008; 283(20): 13780 - 13791.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Bennett, V. Presnyak, J. E. Wedekind, and H. C. Smith
Nuclear Exclusion of the HIV-1 Host Defense Factor APOBEC3G Requires a Novel Cytoplasmic Retention Signal and Is Not Dependent on RNA Binding
J. Biol. Chem., March 21, 2008; 283(12): 7320 - 7327.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.